Pharma stocks buck market weakness as Dr Reddy's gains
- Posted on April 23, 2026
- By Business News Today
- 0 Views
- 1 min read
Pharma stocks buck market weakness as Dr Reddy's gains
Pharma stocks showed strength on Thursday, defying market weakness. Dr Reddy's Laboratories saw significant gains, fueled by anticipation of approval for its Semaglutide diabetes drug in Canada. Other pharma companies also experienced upward movement. This defensive sector appeal is attracting investors amid uncertain market conditions and geopolitical concerns.
